Prudential Financial’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
FLAM
VCM
Prudential Financial's ORGO Position: Q1 2026 in Review
Prudential Financial reduced its Organogenesis Holdings (ORGO) stake by 14% in Q1 2026, selling an estimated $84.1K and leaving 145,900 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #1982.
Prudential Financial first reported a position in ORGO in Q1 2021 and has held it in 21 quarters since. The position peaked at $9.87M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.
- Prudential Financial held 145,900 shares of Organogenesis Holdings worth $346K as of Q1 2026.
- Prudential Financial sold 24,290 Organogenesis Holdings shares in Q1 2026, an estimated $84.1K.
- Organogenesis Holdings made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1982 holding.
- Prudential Financial first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 21 quarters since.
- Prudential Financial's Organogenesis Holdings position peaked at $9.87M in Q2 2021.
- 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.